ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01328106
Recruitment Status : Withdrawn (The study was cancelled by the sponsor prior to initiation of study enrollment. No subjects were accrued.)
First Posted : April 4, 2011
Last Update Posted : December 12, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : August 2011
  Estimated Study Completion Date : May 2012